Clinical Trial Update: A Study of GC203 TIL in Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study of GC203 TIL in advanced malignant solid tumors is currently recruiting across multiple cancer types, including gynecologic, breast, gastroin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Cancer
• Gynecologic Cancer
• Lung Cancer
• Solid Tumor

Drugs mentioned

• GC203 TIL

Snippet

Sponsor: Shanghai Juncell Therapeutics | Conditions: Solid Tumor, Gynecologic Cancer | Phase 1 | Status: RECRUITING